Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors
NCT00003882
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG:
anhydrovinblastine
Sponsor
Roswell Park Cancer Institute